NCT01538121

Antiphospholipid Antibodies and Early Severe Preeclampsia.

Antiphospholipid Antibodies and Early Severe Preeclampsia (< 34 Weeks of Gestation). A Case-Control Study.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 310 (estimated)
• Sponsor: Saint Thomas Hospital, Panama · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

The Antiphospholipid Syndrome is an immune disease where the presence of antibodies directed against cell membrane phospholipids (antiphospholipid antibodies) can cause an hypercoagulable state that causes thrombosis and obstetric complications (miscarriages, stillbirths). Since 1999 the Sapporo Criteria for Antiphospholipid Syndrome diagnosis includes the development of severe preeclampsia before 34 weeks of gestation, but this was done without solid evidence of a relation between the two. Our study will try to add information to this particular point.

Conditions

• Severe Preeclampsia
• Antiphospholipid Syndrome

Timeline

• Start date: 2015-06-01
• Primary completion: 2016-07-01
• Completion: 2016-08-01
• First posted: 2012-02-23
• Last updated: 2015-01-05

Locations

1 site across 1 country: Panama